Dopamine D2 receptor antagonist-1
CAS No. 1055411-77-2
Dopamine D2 receptor antagonist-1( —— )
Catalog No. M26170 CAS No. 1055411-77-2
Dopamine D2 receptor antagonist 1 is a negative allosteric modulator (NAM) of dopamine D2 receptor (D2R), with sub-mM affinity.
Dopamine D2 receptor antagonist 1 is a negative allosteric modulator (NAM) of dopamine D2 receptor (D2R), with sub-mM affinity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 87 | Get Quote |
|
5MG | 147 | Get Quote |
|
10MG | 222 | Get Quote |
|
25MG | 401 | Get Quote |
|
50MG | 592 | Get Quote |
|
100MG | 844 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDopamine D2 receptor antagonist-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionDopamine D2 receptor antagonist 1 is a negative allosteric modulator (NAM) of dopamine D2 receptor (D2R), with sub-mM affinity.
-
DescriptionDopamine D2 receptor antagonist 1 is a negative allosteric modulator (NAM) of dopamine D2 receptor (D2R), with sub-mM affinity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1055411-77-2
-
Formula Weight259.37
-
Molecular FormulaC14H17N3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (963.87 mM)
-
SMILESC1CC(C1)Nc1ncnc2sc3CCCCc3c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Noboru Shoji, et al. Hosenkosides A, B, C, D, and E, novel baccharane glycosides from the seeds of Impatiens balsamina. Tetrahedron. 50, (17),1994 Apr:4973-4986.
molnova catalog
related products
-
Picfeltarraenin X
Picfeltarraenin X shows stronger AChE inhibition than the known AChE inhibitor Tacrine.
-
Sequoiaflavone
Sequoiaflavone is a biflavone isolated from Ginkgo biloba.
-
N-[2-(diethylamino)e...
N-[2-(diethylamino)ethyl]-2-iodobenzamide is a radiopharmaceutical for the scintigraphic detection of melanoma and metastases.